Many thanks to Pulitzer Center, once again, for supporting us on ambitious reporting projects. This is part of a series that's looking at the restructuring of global health architecture in the wake of cuts in foreign aid, primarily by the U.S. government. www.science.org/content/arti...
This drug could help end the HIV epidemic. Its rollout has hit speed bumps
One shot of lenacapavir can protect for 6 months—but aid cuts and uncertain demand mean little drug has reached the countries that most need it
science.org